 |
Ricin (blocked) conjugated murine MCA (anti-my9) |
|---|---|
| Trade Name | |
| Orphan Indication | Myeloid leukemia, including AML, and blast crisis of CML |
| USA Market Approval | USA |
| USA Designation Date | 1989-08-03 00:00:00 |
| Sponsor | ImmunoGen, Inc.;830 Winter Street;Waltham, Massachusetts, 02451 |
